Figure 4From: Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolismSimulated plasma concentrations of rivaroxaban with the venous thromboembolism treatment regimen*. Reproduced with permission from Mueck W et al. [16]. bid, twice daily; od, once daily. *15Â mg bid for 3Â weeks, followed by 20Â mg od.Back to article page